ACTIVE SUBSTANCE / INN

MAFTIVIMAB

Brand name(s): INMAZEB
FDA LISTED
PRESCRIPTION
BLA761169
ACTIVE SUBSTANCE
Maftivimab
REGULATORS
FDA
SPONSORS / MAH
REGENERON PHARMACEUTICALS
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INMAZEBBLA761169REGENERON PHARMACEUTICALSPrescription

FULL INTELLIGENCE ON MAFTIVIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →